Hester Biosciences Ltd - HESTER BIOS Share Price

Sector: Pharmaceuticals | ISIN: INE782E01017
₹ 1,632.90 (0.69%) icon19 Apr, 2024, 12:00:00 AM

Hester Biosciences Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/19/2024 12:00:00 AM

    ₹ 1632.9 11.20 0.69
  • Open
  • ₹ 1,619.2
  • Prev. Close
  • ₹ 1,621.7
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 1,637.1
  • Day's Low
  • ₹ 1,603.6
  • 52 Week's High
  • ₹ 1,939.95
  • 52 Week's Low
  • ₹ 1,292.85
  • Book Value
  • ₹ 366.89
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 1,389.09
  • P/E
  • 53.18
  • EPS
  • 30.55
  • Divi. Yield
  • 0.49

Hester Biosciences Ltd Corporate Actions

24 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Jan , 2024

12:00 AM

27 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

27 Oct , 2023

12:00 AM

23 Aug , 2023

12:00 AM

AGM

Announcement date: 23 Aug , 2023

View Details

17 May , 2023

12:00 AM

Dividend

Dividend amount: 8
Announcement date: 17 May , 2023

View Details

31 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jul , 2023

12:00 AM

26 Jun , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

09 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 Aug , 2023

12:00 AM

BookCloser

View Details

No Record Found


Hester Biosciences Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Hester Biosciences Ltd SHAREHOLDING SNAPSHOT
19 April , 2024 | 07:16 PM

PROMOTER - TOTAL53.73%

Indian: 44.28%

Foreign: 9.4507%

NON-PROMOTER - TOTAL 46.27%

Institutions: 0.43%

Non-Institutions: 45.84%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Hester Biosciences Ltd FINANCIALS

Hester Biosciences Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Hester Biosciences Ltd

  • Bhupendra V Gandhi
  • Chairman & Non Executive Dir.
  • Sanjiv D Gandhi
  • Non-Exec & Non-Independent Dir
  • Nina Gandhi
  • Non Executive Director
  • Sandhya Patel
  • Independent Non Exe. Director
  • Ashok Bhadakal
  • Independent Non Exe. Director
  • Ameet Desai
  • Independent Non Exe. Director
  • Rajiv D Gandhi
  • ED / MD / CEO / Promoter
  • Ravin Gandhi
  • Non-Exec & Non-Independent Dir
  • PRIYA RAJIV GANDHI
  • Executive Director
  • Anil Jain
  • Independent Non Exe. Director
  • Jatin Yagneshbhai Trivedi
  • Independent Non Exe. Director

Summary

Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India. Since its incorporation in Apr 87, the Company has been engaged in the production and distribution of vaccines and health products. Headquartered in Ahmedabad, Gujarat, the Company is currently the second-largest maker of poultry vaccines in India, having acquired strong brand equity over the years. The Company principally engages in two business verticals, namely Poultry Healthcare and Animal Healthcare. Its products are registered with several countries, and internal agencies, and have gained widespread recognition in both India and international markets. It has built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh. The products and services offered include over 51 vaccines and 70+ health products. In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals.The Company markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium.The companys own production of veterinary... Read More


Reports by Hester Biosciences Ltd


Reports by Hester Biosciences Ltd

Company FAQ

No Record Found